Home / Recalls / RISING PHARMACEUTICALS / D-0348-2023

D-0348-2023 Class II Terminated

Recalled by RISING PHARMACEUTICALS — East Brunswick, NJ

Recall Details

Product Type
Drugs
Report Date
March 1, 2023
Initiation Date
February 15, 2023
Termination Date
June 14, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12,216 bottles (100 count each)

Product Description

Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution Pattern

Product was distributed to 16 distributors and 8 wholesalers who may have further distributed the product nationwide.

Code Information

Batch #: NB101596, Exp. 04/30/2023

Other recalls by RISING PHARMACEUTICALS

  • D-0573-2022 Class II — Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Onl (February 7, 2022)
  • D-0005-2022 Class II — Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: (September 2, 2021)
  • D-1368-2020 Class III — Timolol Maleate Sterile Opthalmic Solution,USP 0.25%, 5 mL, Rx Only, For Topical (November 15, 2019)
  • D-1367-2020 Class III — Timolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topi (November 15, 2019)
  • D-1054-2019 Class II — Valsartan Tablets 160 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetri (March 7, 2019)
  • D-1055-2019 Class II — Valsartan Tablets 320 mg USP, 90 tablet bottles, Distributed by: Acetris Health, (March 7, 2019)
  • D-1052-2019 Class II — Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetri (March 7, 2019)
  • D-1053-2019 Class II — Valsartan Tablets 80 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetri (March 7, 2019)